Tepha
Company

Last deal

$25M

Amount

Debt Financing

Stage

01.01.2020

Date

3

all rounds

$60.17M

Total amount

date founded

Financing round

General

About Company
Tepha develops and commercializes absorbable biomaterials for surgical procedures.

Industry

Sector :

Subsector :

founded date

01.01.1998

Number of employees

Company Type

For Profit

Last funding type

Debt Financing

IPO status

Private

Description

The company's proprietary biomaterial technology, polyhydroxyalkanoates (PHAs), provides a new class of absorbable biomaterials that can be tailored to meet unmet needs in multiple medical device fields. Tepha's biosynthetically produced materials offer superior performance in flexibility, elasticity, and biocompatibility, with excellent tensile strength and strength retention for its fiber-based products. With PHAs, Tepha aims to provide innovative products for anterior cruciate ligament repair, intracardiac defect closure, and absorbable cardiovascular stents, among others.
Contacts

Contact Email

Phone number

Similar Companies
1000
TyRx

TyRx

TYRX commercializes medical-pharmaceutical combination devices for multiple surgical markets.

Sector

Medical Equipment and Services

Subsector

Medical Equipment

Keywords

Biotechnology, Health Care, Medical Device

Location

Monmouth Junction, South Brunswick Township, NJ 08852, USA

total rounds

2

total raised

$22M
SyntheMed

SyntheMed

SyntheMed is a biomaterials company that develops and commercializes medical devices for therapeutic applications.

Sector

Medical Equipment and Services

Subsector

Medical Equipment

Keywords

Biotechnology, Health Care, Medical Device

Location

Iselin, Woodbridge Township, NJ, USA
Endomedix

Endomedix

Endomedix is a medical device start-up company that develops hydrogel medical devices using natural biopolymers.

Sector

Medical Equipment and Services

Subsector

Medical Equipment

Keywords

Biotechnology, Health Care, Medical Device

Location

Montclair, NJ, USA

total rounds

2

total raised

$3.1M
Tissue Regeneration Systems

Tissue Regeneration Systems

Tissue Regeneration Systems commercializes skeletal reconstruction and bone regeneration technology.

Sector

Medical Equipment and Services

Subsector

Medical Equipment

Keywords

Medical Device, Biotechnology, Health Care

Location

Kirkland, WA, USA

total rounds

5

total raised

$18.33M
M&A Details
1

Acquired by

Becton, Dickinson and Company (BD)

announced date

27.07.2021

Financials

Funding Rounds
7
3

Number of Funding Rounds

$60.17M

Money Raised

Their latest funding was raised on 01.01.2020. Their latest investor Yield10 Bioscience. Their latest round Debt Financing

Date 
Funding Round 
Investors 
Money Raised 
Lead 
01.01.2020
1
$25M
16.03.2012
$11.3M
18.05.2011
$4.97M
Co-Investors
Investors
6
1

Number of lead investors

6

Number of investors

Investor 
Lead 
Round 
Partners 
Yield10 Bioscience

Yield10 Bioscience

Yield10 Bioscience is developing disruptive technologies to improve crop yield for food and feed crops.

Sector

Chemicals

Subsector

Fertilizers and Other Agrochemicals

Keywords

Chemical, Biotechnology, Agriculture

Location

Woburn, MA, USA

total rounds

8

total raised

$125.39M

count Of Investments

1

count Of Exists

1
Integra Ventures

Integra Ventures

Integra Ventures is a venture capital firm that focuses on investing in healthcare companies on the West Coast of the United States.

Sector

Open End and Miscellaneous Investment Vehicles

Subsector

Open End and Miscellaneous Investment Vehicles

Keywords

Biotechnology, Health Care, Venture Capital

Location

Seattle, WA, USA

count Of Investments

14

count Of Exists

6
Westfield Capital Management

Westfield Capital Management

Westfield Capital Management is an SEC-registered investment advisor.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Financial Services, Venture Capital, Health Care

Location

Boston, MA, USA

count Of Investments

9

count Of Exists

5

People

Founders
1
Anthony J. Sinskey
Anthony J. Sinskey

Anthony J. Sinskey

Anthony J. Sinskey, Sc.D. has served as a member of our board of directors since 1999 and is one of our co-founders. Dr. Sinskey is a Professor of Microbiology and Engineering Systems at The Massachusetts Institute of Technology (MIT) and a Professor of Health Sciences and Technology at the Harvard-MIT Division of Health Sciences and Technology, and he has been a member of the faculty at MIT since 1968. Dr. Sinskey also holds positions as Co-Director of the Malaysia-MIT Biotechnology Partnership Program and as Faculty Director of the Center for Biomedical Innovation. Dr. Sinskey is a co-founder and a member of the boards of directors of Metabolix, Inc. and Tepha, Inc. and a consultant to several chemical and biotechnology companies. Dr. Sinskey holds an Sc.D. from MIT and a B.S. from the University of Illinois, and he was a post-doctoral fellow at the Harvard School of Public Health.

current job

Tepha
Tepha

organization founded

2

Anthony J. Sinskey

Employee Profiles
6

Connie Garrison

SVP, Regulatory, Clinical and Quality Systems

Karen Doyle

Clinical Operations Consultant

Andy Joiner

President & CEO

Said Rizk

Sr. Vice President of Manufacturing and Process Technologies

Anthony J. Sinskey

Anthony J. Sinskey

Co-Founder and Boards of Directors

Activity

Recent News
0